0104 GMT - KPJ Healthcare could post sequentially stronger 2Q core net profit, driven by improving patient volume and revenue intensity, alongside margin recovery, RHB IB analyst Eddy Do says in a note. He tips 2Q core net profit at 92 million ringgit, which is 16% stronger on year and 28% higher sequentially. Additional growth could come from newer hospitals moving into profitability as operations mature, he says. KPJ's third center of excellence launch should also support longer-term revenue growth, he adds. RHB maintains a buy rating on KPJ and keeps its target price at 3.77 ringgit. Shares are unchanged at 3.07 ringgit.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.